Skip to main content
Premium Trial:

Request an Annual Quote

ChondroGene Changes Name to GeneNews, Expects to Begin Trading on TSX By Thursday


NEW YORK (GenomeWeb News0 - Genomics research company ChondroGene has changed its name to GeneNews, the company reported today.
ChondroGene announced its plans to change its name last month, after it received conditional approval to trade on the Toronto Stock Exchange.
The company said it expects to begin trading on the TSX under the symbol GEN "on or about" Thursday, Oct. 26, subject to final approval from the TSX. Its common shares will continue to trade on the TSX Venture Exchange under the symbol CDG until that time.
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.